https://www.cancercenter.com/breast-cancer/risk-factors/tab/triple-negative-breast-cancer-risk-factors/. 
 
 
   [5] Pal SK et al. Triple negative breast cancer: unmet medical needs. 
Breast Cancer Res Treat. 2011;125(3):627--636. 
 
   Roche Group Media Relations 
 
   Phone: +41 61 688 8888 / e-mail: media.relations@roche.com 
https://www.globenewswire.com/Tracker?data=iARt7gI_BiODzCAiYWnjq__ap2Es0JRINIlSzpmhV378HJ_3JwbDwu0tk6WoELbmBhZeLqztgiO8DvUVTr4k5xTHTZ1rhxw_AHIUlQExkiFQM2K4hRRHW0BZv7YbXvpF 
 
 
 
 
 
Dr. Nicolas Dunant          Patrick Barth 
 Phone: +41 61 687 05 17     Phone: +41 61 688 44 86 
Dr. Daniel Grotzky          Karsten Kleine 
 Phone: +41 61 688 31 10     Phone: +41 61 682 28 31 
Nina Mählitz           Nathalie Meetz 
 Phone: +41 79 327 54 74     Phone: +41 61 687 43 05 
Dr. Barbara von Schnurbein 
 Phone: +41 61 687 89 67 
 
 
 
 
 
 
Roche Investor Relations 
Dr. Karl Mahler                        Jon Kaspar Bayard 
 Phone: +41 61 68-78503                 Phone: +41 61 68-83894 
 e-mail: karl.mahler@roche.com          e-mail: jon_kaspar.bayard@roche.com 
Dr. Sabine Borngräber             Dr. Bruno Eschli 
 Phone: +41 61 68-88027                 Phone: +41 61 68-75284 
 e-mail: sabine.borngraeber@roche.com   e-mail: bruno.eschli@roche.com 
Dr. Birgit Masjost                     Dr. Gerard Tobin 
 Phone: +41 61 68-84814                 Phone: +41 61 68-72942 
 e-mail: birgit.masjost@roche.com       e-mail: gerard.tobin@roche.com 
 
Investor Relations North America 
Loren Kalm                             Dr. Lisa Tuomi 
 Phone: +1 650 225 3217                 Phone: +1 650 467 8737 
 e-mail: kalm.loren@gene.com            e-mail: tuomi.lisa@gene.com 
 
 
 
   Attachment 
 
 
   -- 28042021_MR_ Tecentriq_ODAC_mTNBC_EN 
      https://ml-eu.globenewswire.com/Resource/Download/293c5511-7b82-4540-9b56-9027ed37194f

(END) Dow Jones Newswires

April 27, 2021 18:25 ET (22:25 GMT)